CHAT NOW
If a member of my family were diagnosed with cancer, I would want them to be treated at CTCA.
- Location
- Phoenix
- Scottsdale
- Specialties
- Urologic Oncology
- Education
- Medical school:
University of Southern California Keck School of Medicine, Los Angeles, CA - Residency:
Urology - Baylor College of Medicine, Houston, TX - Fellowship:
Urologic Oncology - Baylor College of Medicine, Houston, TX
- Certifications
- Urology – American Board of Urology
"The patient-centered philosophy and collaborative work environment are what drew me here," says Dr. Farshid Sadeghi, Medical Director of Genitourinary Center and a Urologic Oncologist at Cancer Treatment Centers of America ® (CTCA), Phoenix. "These approaches directly influence the delivery of high-quality care."
Dr. Sadeghi studied biochemistry at Harvard College, completing his Bachelor of Arts degree in 1990. He holds a Doctor of Medicine degree from the University of Southern California, in Los Angeles.
Following his academic studies, Dr. Sadeghi completed seven years of professional training at Baylor College of Medicine in Houston, Texas. After a year-long surgical internship, he was a urology resident for five years, awarded Outstanding Resident Teacher in his final year. His subsequent fellowship in urologic oncology included advanced laparoscopic and robotic training in Brussels, Belgium, and Paris, France.
In 2003, Dr. Sadeghi joined a private urology practice in Arizona, where he provided care for more than a decade. During these years, he held several academic appointments as a clinical instructor with the University of Arizona, Midwestern University College of Medicine, and Honor Health.
Dr. Sadeghi has been treating urologic cancers at CTCA® since August 2016. In his prior practice, he was an early adopter of laparoscopic and robotic-assisted surgery for the treatment of prostate, kidney, and bladder cancer, supervising the training of colleagues in the use of the Da Vinci® Robotic Surgical System. His dedicated care and expertise in minimally invasive techniques have made him a sought-after urologic surgeon who is proud to provide care at CTCA. "I want to offer patients optimal outcomes using approaches that allow them to enjoy rapid recovery and fewer side effects," says Dr. Sadeghi.
Dr. Sadeghi has also contributed to the scientific literature. After becoming interested in research as an undergraduate, his laboratory work in medical school generated several significant publications focused on urology, including reports on immunotherapy for prostate cancer.
Licensed to practice medicine by the State of Arizona, Dr. Sadeghi is Board Certified in Urology by the American Board of Urology. He is a member of the Arizona Medical Association, the American Urological Association, and the Society of Urologic Oncology.
Dr. Sadeghi's time outside of CTCA revolves around his family. He enjoys watching his children play soccer and ice skate, and he is always looking forward to his next family vacation abroad. He is also an avid chess player.
- Patient ratings
- Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.